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.\bstract (R,)-cAMPS is known to inhibit competitively the 
CAMP-induced activation of CAMP-dependent protein kinase 
(PKA). The molecular nature of this inhibition, however, is un- 
known. By monitoring the intrinsic tryptophan fluorescence of 
recombinant type I regulatory subunit of PKA under unfolding 
conditions, a free energy value (AGoHzo) of 8.23 + 0.22 kcaUmol 
was calculated. The CAMP-free form of the regulatory subunit 
was less stable with AGDH20 = 6.04 f 0.05 kcallmol. Native sta- 
bility was recovered by treatment of the CAMP-free protein with 
either CAMP or (S&AMPS but not with (R&AMPS. Thus, 
(R&AMPS binding to the regulatory subunit keeps the protein 
in a locked conformation, unable to release the catalytic subunit. 
This finding was further supported by demonstrating that holoen- 
/yme formation was greatly accelerated only when bound CAMP 
was replaced with (R&AMPS but not with CAMP or (S,)- 
t AMPS. 
R’ey words: CAMP-dependent protein kinase; (&)-CAMPS; 
!‘rotein folding; Fluorescence spectroscopy 
/. Introduction 
The activation of CAMP-dependent protein kinase (PKA) 
,tppears to be a rather distinct mechanism within the protein 
sinase family since it involves dissociation of its subunits. The 
Iloloenzyme of PKA is a tetrameric protein which consists of 
,i regulatory subunit dimer (R,) and two catalytic subunits (C). 
ictivation of the complex Z&C2 is mediated by CAMP binding 
!o two in-tandem CAMP-binding sites per regulatory subunit, 
<vhich induces a conformational change and subsequently the 
lissociation of the active catalytic subunits (for reviews see refs. 
1321). 
‘?,C, + 4 CAMP = R,(cAMP), + 2 C. 
Each monomer of the R-subunit contains two distinct 
‘,AMP-binding sites designated A and B. The two sites are 
,.imilar with respect to their primary amino acid sequence [3] 
‘mt differ regarding their CAMP-analog selectivity [4] and over- 
,111 kinetics [2]. The molecular events that eventually lead to 
loloenzyme dissociation require a well defined step-wise occu- 
,,ation of the CAMP-binding sites [5,6]. CAMP binds first to site 
3 of each monomer. Since CAMP binding is cooperative [7,8], 
occupation of site B induces a conformational change that 
dlows CAMP-binding to site A which mediates dissociation of 
he C-subunit. In this model site A provides the major contact 
‘Corresponding autor. Fax: (49) (89) 3849-3261. 
with the C-subunit which was further supported by studies with 
PKA mutants [9-l l] and CAMP-analogs [12]. 
Holoenzyme dissociation is competitively inhibited by (Rp)- 
CAMPS, a CAMP-analog with a sulfur substitution at the equa- 
torial exocyclic phosphate-oxygen [13,14] as shown in Fig. 1. 
In contrast, the diasteriomeric (&)-CAMPS acts as a CAMP 
agonist [ 131. So far, ( R,)-CAMPS and its nucleo-base modified 
derivatives [ 15,161 are the only known potent antagonists of the 
type I and II kinases. 
The recent solution of a 2.8 A resolution crystal structure of 
a deletion form of the type I R-subunit [17] revealed the archi- 
tecture of the two CAMP-binding sites and structural details of 
the amino acid residues involved in CAMP binding, particularly 
the cyclic phosphate moiety. In both binding sites the equato- 
rial exocyclic phosphate-oxygens of CAMP interact specifically 
with the guanidinium side chain of an invariant arginine at 
positions 209 and 333 known to be important for CAMP bind- 
ing [lO,l I]. Thus, the structure explains the low binding-affini- 
ties observed for (R,)-CAMPS and its derivatives [ 15,161. How- 
ever, the molecular nature of the holoenzyme inhibition cannot 
be deduced from the structure alone. 
Fluorescence-spectroscopy was employed in order to probe 
the changes in conformational stability that take place upon 
CAMP binding to the R-subunit. In addition. the changes in 
protein stability when switching from the natural ligand to 
(&)-CAMPS and (&)-CAMPS were determined. The free-en- 
ergy changes (AG, Hzo) for the wild-type regulatory subunit 
were compared to a mutant form (Arg’O’Lys) which abolishes 
high affinity CAMP binding to site A [IO,1 11. 
2. Materials and methods 
2. I. Adenosine cyclic-3’,5’-phosphorothioates 
The purities of (Rp)- and (S&AMPS were analyzed by Reversed- 
Phase-HPLC. Removal of CAMP contamination was achieved by incu- 
bating 10 mM (&)-CAMPS in buffer A (10 mM Tris-HCl, pH 7.6, 
2 mM MgCI,) and 300 &ml 3’,5’-cyclic nucleotide phosphodiesterase 
(Boehringer), since the enzyme cannot hydrolyze (R,)-CAMPS [l&19]. 
(&)-CAMPS was free of CAMP. A control experiment showed that 
untreated (R,)-CAMPS samples at concentrations >50,~M activated the 
holoenzyme type I, commensurate with the low levels of CAMP contam- 
ination that were observed. In contrast, the PDE-treated sample did not 
activate up to 1 mM (R&CAMPS. Before use, (R,)- and (&)-CAMPS 
were checked routinely by HPLC to verify that no contaminating 
CAMP was present. 
2.2. Protein preparations 
The recombinant type I regulatory subunit was expressed and puri- 
fied according to Saraswat et al. [20]. The mutant type I regulatory 
subunit R209K was obtained as described previously [IO]. CAMP free 
R-subunit was prepared by incubating l-2 PM protein in 5 M urea, 50 
mM MES, pH 6.5. 5 mM 2-mercaptoethanol for 3 h. This urea concen- 
tration was sufficient to abolish CAMP binding but not high enough to 
totally denature the protein [21]. The precaution was indispensable to 
assure proper refolding of the protein. The mixture was then passed 
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over a G-25 gel filtration column equilibrated with 5 M urea, 50 mM 
MES, pH 6.5, 5 mM 2-mercaptoethanol to remove CAMP. Removal of 
urea and refolding of stripped R-subunit was accomplished by a second 
G-25 gel filtration run without urea. Protein concentrations (0.25~0.5 
PM) were determined according to Bradford [22] and the fraction of 
unoccupied CAMP binding sites determined by measuring the amount 
of bound [‘HIcAMP at 0°C using an ammoniumsulfat precipitation 
assay as described previously [23]. Under these conditions bound 
CAMP will not exchange with [‘HIcAMP rapidly. On average 95% of 
the CAMP binding sites were free of CAMP for the urea stripped pro- 
teins. Reloading of the stripped wild type and Arg*“Lys mutant R- 
subunits with cyclic nucleotides was accomplished by a 3 h incubation 
with a 3-fold excess of CAMP, 15-fold (&)-CAMPS and 60-fold (Rp)- 
CAMPS. 
2.3. Fluorescrnce measurements 
The protein solutions were incubated in various concentrations of 
denaturant (O-8 M urea) to give a final protein concentration of 0.25 
PM. The mixtures were then allowed to come to equilibrium for 3 h at 
room temperature. All fluorescence measurements were performed at 
least in dublicate on a Spectrofluorometer (SLM Aminco SPF-500). 
The protein samples were excited at 293 nm, and the tryptophan emis- 
sion was monitored at 347 nm. The resulting emission spectra were then 
followed from 300 nm to 400 nm. A fluorescence intensity ratio (353 
nn~340 nm) was used to follow the shift in wavelength since the native 
form and the denatured form of the wild type protein displayed maxima 
at 340 and 353 nm, respectively. The data was then used to construct 
an unfolding curve (Fig. 2) using the following equation: 
F,, = 1 -[U-M~,-4,)1 (1) 
where F, is the fraction of unfolding, IO is the observed intensity ratio 
at various urea concentrations, and IN and ZD are the fluorescence 
intensity ratios of the fully folded und unfolded proteins, respectively 
[24]. A two-state model, represented by FN + F, = 1 where FN is the 
fraction of native protein and F, is the fraction of unfolded protein, was 
then used to calculate the free energy of denaturation dGo [25] accord- 
ing to equation (2). 
FNIFL, = K, 
K ” = e -Km,/77 (2) 
-RT In (F,_,/F,) = AGJ 
G,,H20 in the absence of denaturant [25] was obtained according to 
equation (3). (inset of Fig. 2): 
dG, = dG,,“z” - m [denaturant] 
2.4. Holoenz)we formation 
(3) 
In order to determine the rate of holoenzyme formation a dialysis 
technique has been used as described previously [12]. Urea stripped wild 
type R-subunit (0.25 PM) which had been recovered with either CAMP, 
(&)-CAMPS or (R,)-CAMPS was dialyzed with C-subunit at a 1 : 1.1 
molar ratio at room temperature. At designated time points aliquots 
were removed and the remaining catalytic activity monitored by the 
coupled photo-spectrometric assay according to Cook et al. [26]. 
NH2 NH2 
c?3 OH 
S ,-CAMPS R,.CAMPS 
Fig. 1. Chemical structures of (R,)-CAMPS and (&)-CAMPS. 
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Fig. 2. Urea induced unfolding of the regularory subunit in the presence 
(v) and absence (A) of excess CAMP. The fraction of unfolded protein 
(FJ was determined according to equation (1). The inset shows the 
equilibrium unfolding transition as a function of denaturant. The dG, 
values were calculated (equation (2)) from the unfolding curves in the 
presence (v) and absence (A) of excess CAMP. 
3. Results 
3.1. Fluorescence measurements under unjblding conditions 
Unfolding of the regulatory subunit of PKA is accompanied 
by a shift of the tryptophan fluorescence emission maximum 
from 340 nm (native form) to 353 nm (unfolded form) (data not 
shown). Thus, the unfolding process was followed by monitor- 
ing the fluorescence intensity ratio, I(353 nmI340 nm) as shown 
in Fig. 2. When native R-subunit was urea denatured the con- 
centration midpoint of unfolding C,,, was 5.55 M. In contrast, 
denaturation of CAMP-free R-subunit resulted in a shift to the 
left (C,, = 5.10 M urea), which is indicative of an increased 
sensitivity towards denaturation. This experiment demon- 
strated that bound CAMP stabilizes the R-subunit as has been 
described by Leon et al. [21]. The transition region of the un- 
folding curves is linear if one assumes a two-state model [25] 
and allows calculation of the free energy of denaturation (AC,) 
for this unfolding curve. By linear extrapolation of the AC, 
values, the free energy of denaturation at zero concentration 
of denaturant (dGDHzo) was calculated (inset of Fig. 2, Fig. 3). 
In order to investigate the effects of bound (&)- and (S,)- 
CAMPS on the thermodynamics of R-subunit unfolding, urea 
stripped, CAMP-free protein was incubated with an excess of 
(Rp)- or (&)-CAMPS. Incubation of the urea stripped R-sub- 
unit with CAMP served as a control experiment to assure that 
the protein was capable of regaining native stability. As shown 
in Fig. 3, dGDH2’ of the R-subunit, in its native form was 
determined as 8.23 f. 0.22 kcal/mol. The protein has CAMP 
bound with high affinity [27]. Treatment of the regulatory sub- 
unit in 5 M urea is sufficient to obliterate CAMP binding, while 
the protein is still to a large extent in its natural folded state [21]. 
This CAMP free form of the regulatory subunit was signifi- 
cantly less stable as indicated in a AG,“2’ value of 6.04 f 0.05 
kcal/mol. By adding CAMP or (&)-CAMPS back to the CAMP 
free form of the protein the native stability could be regained 
(Fig. 3, panels 3 and 4). However, addition of (R,)-CAMPS to 
the CAMP free protein was not capable of recovering the native 
stability (Fig. 3, panel 5). Since (S,)- and (R,)-CAMPS have 
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lower affinities to the CAMP binding sites the concentrations 
01‘ added CAMP analog were adjusted according to their bind- 
ing affinities [15]. 
The regulatory subunit type la contains three tryptophan 
residues at positions 188, 222 and 260, all of which are located 
within CAMP binding site A. In order to prove that the ob- 
s,:rved changes in free energy (dGnH?o) are only associated with 
s te A, we studied a mutant form of the regulatory subunit in 
\ hich residue Arg’“” of the CAMP binding site A was changed 
t ) Lys. This mutant, Arg’““Lys, abolishes high affinity binding 
c f CAMP to site A with an K, of > 1 ,uM [ IO,1 11. When denatu- 
I ttion experiments were repeated with the Arg’O’Lys R-subunit 
I mtant no changes in free energy were observed (data not 
s rown). AGDHZo values of 5.0 + 0.8 kcaVmo1 were obtained 
I zgardless whether the mutant was stripped off bound CAMP 
( r not. Addition of (Rp)- or (&)-CAMPS had no effect. too. 
Y,loreover, AG,H”o for the Arg’“‘Lys-mutant equaled that for 
t te CAMP-free wild type. Thus, the stability of the CAMP free 
\ .ild type protein and the mutant form of the regulatory subunit 
2 re remarkable similar. 
_ 2. Hohnzyme Jtirrnution 
When urea stripped wild type R-subunit was incubated with 
; 3-fold excess of CAMP at room temperature, more than 97% 
t f the CAMP-binding sites were occupied within 15 min as was 
1 etermined by [‘HIcAMP exchange (see section 2.2.). Fig. 4 
? lows the reassociation of regulatory and catalytic subunits 
I nder equilibrium dialysis conditions. The R-subunits were 
:;ripped of CAMP and subsequently reloaded with either 
1 AMP, (&)- or (&)-CAMPS as described in section 2. Holoen- 
; yme formation was notably increased when the R-subunit had 
( &,)-CAMPS bound prior to the dialysis with a half-life of 
I oloenzyme formation (r,,,) of 30 min. Similarly, the Arg’“‘Lys- 
I mtant R-subunit displayed an enhanced rate of holoenzyme 
t 3rmation as described recently [lo]. In contrast, (&)-CAMPS 
t r CAMP treated protein samples showed a 6-fold shift with r,,? 
alues of 180 min. Thus, (R,)-CAMPS bound R-subunit is able 
10 -I 
I ‘ig. 3. Free energy changes (dGoH2”) were calculated by linear regres- 
-ton of the unfolding transition data (inset of Fig. 2) according to 
Lquation (3). Panel I: native R-subunit; panel 2: urea stripped, CAMP- 
tree R-subunit; panel 3: urea stripped R-subunit + excess CAMP; panel 
J: urea stripped R-subunit + excess (&)-CAMPS; panel 5: urea stripped 
R-subunit + excess (R,)-CAMPS. In the experiments described in panel 
t-5, the cyclic nucleotides were added prior to denaturation. 
(I 50 IM ml 300 350 1100 
Time (min) 
Fig. 4. Time course of holoenzyme formation in the presence of 
MgATP by equilibrium dialysis at room temperature. The remaining 
phosphotransferase ativity of unbound catalytic subunit was measured 
[26] and plotted against the time of dialysis. Prior to the dialysis regu- 
latory subunit was stripped off CAMP as described in section 2, re- 
loaded by either an excess of CAMP (v). (&)-CAMPS (m) or (S,)- 
CAMPS (A,) and mixed with C-subunit in a I : 1. I molar ratio. 
to complex the C-subunit more efficiently, than native CAMP 
bound R-subunit does. 
4. Discussion 
The regulatory subunit of PKA exists in vivo of two stable 
conformations: the CAMP-bound conformation (B-form) in 
which the protein is stable in solution and an in the CAMP-free 
holoenzyme conformation (H-form). In the H-form the R-sub- 
unit can only exist when complexed with the catalytic subunit 
s21. 
RzC2 + 4 CAMP = R,(cAMP), + 2 C 
H-form B-form 
Obviously, CAMP binding induces a conformational shift 
from H-form to B-form. This change in conformation is the 
molecular basis for the allosteric regulation of the enzyme. The 
crystal structure of the R-subunit allowed to analyze the spe- 
cific ligand-receptor interactions on an atomic scale [17]. In 
particular, the exocyclic oxygens of the phosphate moiety dis- 
play a meticulous network of interactions for each site which 
are severely disturbed by either equatorial or axial sulfur substi- 
tution [17] and thus, explains the lower binding affinities ob- 
served for (Rp)-, and (&.)-CAMPS [15] and the relative low 
inhibition constant for (R,)-CAMPS (K, = 7.9pM (131) (Fig. 1). 
Furthermore, the crystal structure revealed that in the CAMP- 
binding site A the side chain of residue Arg’09 which interacts 
specifically with the equatorial position of the phosphate, is 
also linked to As~“~‘. (R,)-CAMPS will prevent this linkage that 
extends beyond the immediate CAMP-binding site by breaking 
the interaction with Arg209 [17]. Whether the signaling by 
CAMP-binding involves Asp”’ remains to be seen. However, 
the results obtained from the fluorescence experiments pre- 
sented in this work indicate that (R,)-CAMPS binding to site 
A is sufficient to induce the observed effects. 
In conclusion, (R,)-CAMPS cannot induce a conformational 
234 
shift necessary for dissociating the PKA holoenzyme, which is 
also in accordance with earlier observations [14,28]. Therefore, 
(&)-CAMPS locks the regulatory subunit in the holoenzyme 
conformation (H-form). This ‘H-form-(I&]-CAMPS-bound R- 
subunit’ reassociates faster with the C-subunit, since the protein 
is already in the suitable ‘H-form’ conformation as was shown 
with the dialysis experiments. These findings are in agreement 
with the results obtained with a mutant form of the R-subunit 
(Arg209Lys) which abolishes high affinity CAMP to binding site 
A [lO,ll]. 
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